Hereditary sensory and autonomic neuropathy
| Hereditary sensory and autonomic neuropathy | |
| ICD-9 | 356.2 |
|---|---|
| OMIM | 162400 201300 223900 256800 608654 |
| DiseasesDB | 32501 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 |
| MeSH | D009477 |
Hereditary sensory and autonomic neuropathy (HSAN) or hereditary sensory neuropathy (HSN) is a condition used to describe one of five diseases[1] which inhibit sensation.
They are less common than Charcot-Marie-Tooth disease.[2]
Classification
Five clinical different entities have been described under hereditary sensory and autonomic neuropathies – all characterized by progressive loss of function that predominantly affects the peripheral sensory nerves. Their incidence has been estimated to be about 1 in 25,000.
Type I, Hereditary sensory radicular neuropathy
Type I, hereditary sensory radicular neuropathy, is the most common of the hereditary sensory and autonomic neuropathies (HSAN). It is transmitted as autosomal dominant trait and is characterized by a sensory deficit in the distal portion of the lower extremities, chronic perforating ulcerations of the feet and progressive destruction of underlying bones. Symptoms appear in late childhood on early adolescence with trophic ulcers as pain sensation is affected more. Many patients have accompanying nerve deafness and atrophy of the peroneal muscles. Histopathologic examination reveals a marked reduction in the number of unmyelinated fibers. Motor nerve conduction velocities are normal, but the sensory nerve action potentials are absent.
Type II, Congenital sensory neuropathy
Type II, congenital sensory neuropathy or Morvan's disease[3], is characterized by onset of symptoms in early infancy or childhood. Upper & lower extremities are affected with chronic ulcerations and multiple injuries to fingers and feet. Pain sensation is affected predominantly and deep tendon reflexes are reduced. Autoamputation of the distal phalanges is common and so is neuropathic joint degeneration. The NCV shows reduced or absent sensory nerve action potentials and nerve biopsy shows total loss of myelinated fibers and reduced numbers of unmyelinated fibers. It is inherited as an autosomal recessive condition.
Type III, Familial dysautonomia
Type III, familial dysautonomia (FD) or Riley-Day syndrome, is an autosomal recessive disorder seen predominantly in Jews of eastern European descent. Patients present with sensory and autonomic disturbances. Newborns have absent or weak suck reflex, hypotonia and hypothermia. Retarded physical development, poor temperature and motor in coordination are seen in early childhood. Other features include reduced or absent tears, depressed deep tendon reflexes, absent corneal reflex, postural hypotension and relative indifference to pain. Scoliosis is frequent. Intelligence remains normal. Many patients die in infancy and childhood. Lack of flare with intradermal histamine is seen. Histopathology of peripheral nerve shows reduced number of myelinated and non-myelinated axons. The catecholamine endings are absent.
Type IV, Congenital insensitivity to pain with anhidrosis
Type IV, congenital insensitivity to pain with anhidrosis (CIPA), is an autosomal recessive condition and affected infants present with episodes of hyperthermia unrelated to environmental temperature, anhidrosis and insensitivity to pain. Palmar skin is thickened and charcot joints are commonly present. NCV shows motor and sensory nerve action potentials to be normal. The histopathology of peripheral nerve biopsy reveals absent small unmyelinated fibers and mitochondria are abnormally enlarged.
Type V, Congenital insensitivity to pain with partial anhidrosis
Type V, congenital insensitivity to pain with partial anhidrosis[3], also manifests with congenital insensitivity to pain & anhidrosis. There is a selective absence of small myelinated fibers differentiating it from Type IV (CIPA).
Associated genes
| Type | Gene | Locus |
| HSAN1 | SPTLC1[4] | 9q22.1-q22.3 |
| HSAN2 | HSN2[5] | 12p13.33 |
| HSAN3 (Familial dysautonomia) | IKBKAP | 9q31 |
| HSAN4 (CIPA) | NTRK1 | 1q21-q22 |
| HSAN5 | NGFß[6][7] | 1p13.1 |
| NTRK1[8] |
References
- ↑ "eMedicine - Autonomic Neuropathy : Article by Cory Toth".
- ↑ Houlden H, Blake J, Reilly MM (2004). "Hereditary sensory neuropathies". Curr. Opin. Neurol. 17 (5): 569–77. PMID 15367861. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 Felicia B Axelrod and Gabrielle Gold-von Simson (October 3, 2007). "Hereditary sensory and autonomic neuropathies: types II, III, and IV". Orphanet Journal of Rare Diseases. 2 (39). doi:10.1186/1750-1172-2-39. PMC 2098750. PMID 17915006. Retrieved 2008-11-04.
- ↑ Houlden H, King R, Blake J; et al. (2006). "Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I)". Brain. 129 (Pt 2): 411–25. doi:10.1093/brain/awh712. PMID 16364956. Unknown parameter
|month=ignored (help) - ↑ Lafreniere RG, MacDonald ML, Dube MP; et al. (2004). "Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates". Am. J. Hum. Genet. 74 (5): 1064–73. doi:10.1086/420795. PMID 15060842. Unknown parameter
|month=ignored (help) - ↑ Einarsdottir E, Carlsson A, Minde J; et al. (February 19, 2004). "A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception". Hum. Mol. Genet. 13 (8): 799–805. doi:10.1093/hmg/ddh096. PMID 14976160. Retrieved 2008-11-04.
- ↑ Minde J, Toolanen G, Andersson T; et al. (2004). "Familial insensitivity to pain (HSAN V) and a mutation in the NGFB gene. A neurophysiological and pathological study". Muscle Nerve. 30 (6): 752–760. PMID 15468048. Unknown parameter
|month=ignored (help) - ↑ Henry Houlden, R. H. M. King, A. Hashemi-Nejad; et al. (2001). "A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V". Annals of Neurology. 49 (4): 521–525. doi:10.1002/ana.103. PMID 11310631. Unknown parameter
|month=ignored (help)